{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:33:37Z","timestamp":1761824017771,"version":"build-2065373602"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.coi.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T18:55:20Z","timestamp":1525460120000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Influenza vaccines: \u2018tailor-made\u2019 or \u2018one fits all\u2019"],"prefix":"10.1016","volume":"53","author":[{"given":"Giulietta","family":"Saletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus F","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.04.015_bib0590","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.015_bib0595","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.015_bib0600","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.coi.2018.04.015_bib0605","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0610","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.coi.2018.04.015_bib0615","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coi.2018.04.015_bib0620","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.coi.2018.04.015_bib0625","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1073\/pnas.79.15.4800","article-title":"Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes","volume":"79","author":"Krystal","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.015_bib0630","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/333426a0","article-title":"Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid","volume":"333","author":"Weis","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.04.015_bib0635","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.04.015_bib0640","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0645","first-page":"21025","article-title":"Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 mid-season results","volume":"20","author":"Pebody","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coi.2018.04.015_bib0650","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrmicro.2017.146","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coi.2018.04.015_bib0655","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/jinf.2000.0652","article-title":"Influenza virus: a master of metamorphosis","volume":"40","author":"De Jong","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.coi.2018.04.015_bib0660","doi-asserted-by":"crossref","first-page":"e1006271","DOI":"10.1371\/journal.ppat.1006271","article-title":"Complete mapping of viral escape from neutralizing antibodies","volume":"13","author":"Doud","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.04.015_bib0665","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1999.9732","article-title":"Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses","volume":"258","author":"Gambaryan","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.04.015_bib0670","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0042-6822(87)90040-7","article-title":"Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus","volume":"160","author":"Robertson","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.04.015_bib0675","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/303706a0","article-title":"Evidence for host-cell selection of influenza virus antigenic variants","volume":"303","author":"Schild","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.04.015_bib0680","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1586\/14760584.2015.1075883","article-title":"Safety, immunogenicity and infectivity of new live attenuated influenza vaccines","volume":"14","author":"Isakova-Sivak","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.015_bib0685","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib0690","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coi.2018.04.015_bib0695","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jiu190","article-title":"Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines","volume":"210","author":"Sasaki","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0700","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barria","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0705","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.015_bib0710","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coi.2018.04.015_bib0715","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0720","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/jiw608","article-title":"Induction of broadly cross-reactive stalk-specific antibody responses to influenza group 1 and group 2 hemagglutinins by natural H7N9 virus infection in humans","volume":"215","author":"Liu","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0725","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2018.04.015_bib0730","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.015_bib0735","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.04.015_sbref0740","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.04.015_bib0745","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.015_bib0750","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2018.04.015_sbref0755","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.04.015_bib0760","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","article-title":"A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza A virus particle release","volume":"17","author":"Yamayoshi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2018.04.015_bib0765","doi-asserted-by":"crossref","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","article-title":"Mechanisms of hemagglutinin targeted influenza virus neutralization","volume":"8","author":"Brandenburg","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coi.2018.04.015_bib0770","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0775","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"de Vries","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib0780","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/infdis\/jix546","article-title":"Primary human influenza B virus infection induces cross-lineage hemagglutinin stalk-specific antibodies mediating antibody-dependent cellular cytoxicity","volume":"217","author":"de Vries","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0785","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_sbref0790","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2018.04.015_sbref0795","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.04.015_bib0800","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_sbref0805","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2018.04.015_sbref0810","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.015_bib0815","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","article-title":"Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain","volume":"88","author":"Eggink","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0820","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0825","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/JVI.02372-15","article-title":"Sequential infection in ferrets with antigenically distinct seasonal H1N1 influenza viruses boosts hemagglutinin stalk-specific antibodies","volume":"90","author":"Kirchenbaum","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0830","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0835","first-page":"275","article-title":"Influenza neuraminidase as a vaccine antigen","volume":"386","author":"Eichelberger","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0840","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0845","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1128\/JVI.01203-13","article-title":"Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses","volume":"87","author":"Wan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0850","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0855","doi-asserted-by":"crossref","first-page":"e0124677","DOI":"10.1371\/journal.pone.0124677","article-title":"A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells","volume":"10","author":"Simhadri","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coi.2018.04.015_bib0860","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.015_bib0865","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib0870","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"Lamere","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0875","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0880","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0885","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0890","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2018.04.015_bib0895","first-page":"818","article-title":"Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0900","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.micinf.2008.07.002","article-title":"Heterosubtypic immunity to influenza A virus: where do we stand?","volume":"10","author":"Grebe","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coi.2018.04.015_bib0905","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1084\/jem.165.2.408","article-title":"Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes","volume":"165","author":"Gotch","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0910","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"issue":"Pt 4","key":"10.1016\/j.coi.2018.04.015_bib0915","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1099\/0022-1317-67-4-719","article-title":"Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes","volume":"67","author":"McMichael","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0920","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.015_bib0925","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1128\/JVI.02536-12","article-title":"Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation","volume":"87","author":"Bodewes","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0930","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0935","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1128\/JVI.02694-07","article-title":"Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus","volume":"82","author":"Kreijtz","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0940","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.00519-10","article-title":"Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus","volume":"84","author":"Tu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0945","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02843-13","article-title":"Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus","volume":"88","author":"van de Sandt","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0950","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","article-title":"Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge","volume":"175","author":"Bender","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.04.015_bib0955","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4049\/jimmunol.1200571","article-title":"Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection","volume":"190","author":"Hamada","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib0960","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/infdis\/jiv018","article-title":"Human influenza A virus-specific CD8+ T-cell response is long-lived","volume":"212","author":"van de Sandt","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib0965","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.033076-0","article-title":"Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells","volume":"92","author":"Hillaire","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib0970","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib0975","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib0980","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2018.04.015_bib0985","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2018.04.015_sbref0990","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2018.04.015_sbref0995","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2018.04.015_sbref1000","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/ncomms7833","article-title":"Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2018.04.015_bib1005","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"issue":"Suppl. 5","key":"10.1016\/j.coi.2018.04.015_bib1010","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.cmi.2015.12.005","article-title":"Universal influenza vaccines: a realistic option?","volume":"22","author":"de Vries","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coi.2018.04.015_bib1015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib1020","doi-asserted-by":"crossref","first-page":"e48322","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2018.04.015_bib1025","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/JVI.06586-11","article-title":"A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication","volume":"86","author":"Cao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib1030","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1128\/JVI.79.17.11239-11246.2005","article-title":"Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes","volume":"79","author":"Berkhoff","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib1035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JVI.02439-15","article-title":"Differential recognition of influenza A viruses by M158-66 epitope-specific CD8+ T cells is determined by extraepitopic amino acid residues","volume":"90","author":"van de Sandt","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.015_bib1040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3389\/fimmu.2017.01760","article-title":"AS03- and MF59-Adjuvanted influenza vaccines in children","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.015_bib1050","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1016\/j.vaccine.2014.08.068","article-title":"Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children","volume":"32","author":"Nolan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1055","doi-asserted-by":"crossref","first-page":"e95496","DOI":"10.1371\/journal.pone.0095496","article-title":"Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization","volume":"9","author":"Khurana","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coi.2018.04.015_bib1060","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2018.04.015_bib1065","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","author":"Stephenson","year":"2005","journal-title":"J Infect D"},{"key":"10.1016\/j.coi.2018.04.015_bib1070","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2017.04.029","article-title":"A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines","volume":"35","author":"Chada","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1075","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2016.02.012","article-title":"Comparison of AS03 and Alum on immune responses elicited by A\/H3N2 split influenza vaccine in young, mature and aged BALB\/c mice","volume":"34","author":"Yam","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2017.05.009","article-title":"Distinct patterns of cellular immune response elicited by influenza non-adjuvanted and AS03-adjuvanted monovalent H1N1(pdm09) vaccine","volume":"144","author":"Giarola-Silva","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coi.2018.04.015_bib1085","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.1101764","article-title":"MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action","volume":"188","author":"Caproni","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1090","article-title":"Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination","volume":"17","author":"Galassie","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.coi.2018.04.015_bib1095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.vaccine.2004.09.002","article-title":"Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity","volume":"23","author":"Bungener","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1586\/14760584.2013.811195","article-title":"Influenza virosomes as vaccine adjuvant and carrier system","volume":"12","author":"Moser","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.015_bib1105","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2005.04.026","article-title":"The virosome concept for influenza vaccines","volume":"23","author":"Huckriede","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1110","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0264-410X(00)00310-8","article-title":"A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines","volume":"19","author":"Rimmelzwaan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/cimm.2001.1835","article-title":"Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function","volume":"211","author":"Sambhara","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1120","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1016\/j.vaccine.2014.08.003","article-title":"Novel G3\/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine","volume":"32","author":"van de Sandt","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1130","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1016\/j.vaccine.2017.09.019","article-title":"Differential gene expression elicited by children in response to the 2015\u201316 live attenuated versus inactivated influenza vaccine","volume":"35","author":"Cole","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12920-017-0304-z","article-title":"Differential responses of innate immunity triggered by different subtypes of influenza a viruses in human and avian hosts","volume":"10","author":"Cao","year":"2017","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.coi.2018.04.015_bib1140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jiu079","article-title":"Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children","volume":"210","author":"Cao","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.015_bib1150","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/j.vaccine.2017.09.058","article-title":"Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells","volume":"35","author":"Forero","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.015_bib1155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2018.04.015_bib1160","doi-asserted-by":"crossref","first-page":"24402","DOI":"10.1038\/srep24402","article-title":"Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies","volume":"6","author":"Schotsaert","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.04.015_bib1165","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1038\/s41598-017-14931-7","article-title":"Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain","volume":"7","author":"Anderson","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.04.015_sbref1170","doi-asserted-by":"crossref","first-page":"e1005702","DOI":"10.1371\/journal.ppat.1005702","article-title":"Two escape mechanisms of influenza a virus to a broadly neutralizing stalk-binding antibody","volume":"12","author":"Chai","year":"2016","journal-title":"PLoS Pathog"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:44:56Z","timestamp":1760604296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517301966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":117,"alternative-id":["S0952791517301966"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.04.015","relation":{},"ISSN":["0952-7915"],"issn-type":[{"type":"print","value":"0952-7915"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza vaccines: \u2018tailor-made\u2019 or \u2018one fits all\u2019","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}